04 September 2020 : Original article
Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells
Zhuo-Qing Li1BCDEF, Hong Shen2BCDE, Kun-Xian Shu3BCDF, Jian-Jun Li1BCDF, Yin Tang4BCD, Jing-Jing Su4BCF, Jun Yan1BCD, Jie Yang3BCF, Ze-Qing Wang1BCF, Yan Qiu4BC, Yong Yang1CF, Yang Liu4CF, Yong Zhou5BDEG*DOI: 10.12659/AOT.925013
Ann Transplant 2020; 25:e925013

Figure 6 Production of C-caspase 3 and cytochrome C proteins in tumor cells and normal cells. (A) Western blot images. Relative C-caspase 3 and cytochrome C expression in HepG2 (B), A549 (C), BGC-803 (D), and HUVEC (E) was statistically analyzed. 1 – Tumor cells (HepG2, A549, BGC-803, or HUVEC cells) without transfection, 2 – Tumor cells (HepG2, A549, BGC-803, or HUVEC cells) transfected with pAAV-IRES-ZsGreen, pHelper, and pAAV-RC, 3 – Tumor cells (HepG2, A549, BGC-803, or HUVEC cells) transfected with pAAV-HE1B19K-TE1A, pHelper, and pAAV-RC). * p<0.05 vs. pAAV-IRES-ZsGreen group in HepG2, A549, or BGC-803 cells.